MicroRNAs have been reported to be implicated in myocardial ischemia/reperfusion (I/R) injury. The purpose of this study was to investigate the effect of miR-183-5p on I/R injury. Overexpression of miR-183-5p by agomiR transfection alleviated cardiac dysfunction and significantly reduced the infarct size in rats with myocardial I/R. MiR-183-5p also alleviated myocardial apoptosis with reduced apoptotic cells and lower levels of apoptosis associated proteins. in vitro experiments were conducted on rat H9c2 cells treated with anoxia/reoxygenation (A/R). Annexin V/propidium iodide (PI) staining and flow cytometry reported that the ratio of apoptotic cells decreased by miR-183-5p transfection before A/R treatment. Moreover, according to binding sequence prediction and Dual luciferase reporter assay, we explored that voltage-dependent anion channel 1 (VDAC1), which aggravates myocardial injury and apoptosis reported in our former research, was a target of miR-183-5p. In conclusion, miR-183-5p can efficiently attenuate I/R injury and miR-183-5p may exert its effect through repressing VDAC1 expression.
基金:
Beijing Hospitals Authority Youth Programme [QML 20180602]; Beijing Municipal Administration of Hospitals' Clinical Medicine Development of Special Funding Support [ZYLX201810]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81471902, 81871592]
第一作者机构:[1]Capital Med Univ, Beijing Anzhen Hosp, Ctr Anesthesiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Anzhen Hosp, Ctr Anesthesiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
Lin Duomao,Cui Boqun,Ma Jun,et al.MiR-183-5p protects rat hearts against myocardial ischemia/reperfusion injury through targeting VDAC1[J].BIOFACTORS.2019,-.doi:10.1002/biof.1571.
APA:
Lin, Duomao,Cui, Boqun,Ma, Jun&Ren, Jiayue.(2019).MiR-183-5p protects rat hearts against myocardial ischemia/reperfusion injury through targeting VDAC1.BIOFACTORS,,
MLA:
Lin, Duomao,et al."MiR-183-5p protects rat hearts against myocardial ischemia/reperfusion injury through targeting VDAC1".BIOFACTORS .(2019):-